Cargando…

Deep learning for in vitro prediction of pharmaceutical formulations

Current pharmaceutical formulation development still strongly relies on the traditional trial-and-error methods of pharmaceutical scientists. This approach is laborious, time-consuming and costly. Recently, deep learning has been widely applied in many challenging domains because of its important ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yilong, Ye, Zhuyifan, Su, Yan, Zhao, Qianqian, Li, Xiaoshan, Ouyang, Defang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362259/
https://www.ncbi.nlm.nih.gov/pubmed/30766789
http://dx.doi.org/10.1016/j.apsb.2018.09.010
_version_ 1783392878609825792
author Yang, Yilong
Ye, Zhuyifan
Su, Yan
Zhao, Qianqian
Li, Xiaoshan
Ouyang, Defang
author_facet Yang, Yilong
Ye, Zhuyifan
Su, Yan
Zhao, Qianqian
Li, Xiaoshan
Ouyang, Defang
author_sort Yang, Yilong
collection PubMed
description Current pharmaceutical formulation development still strongly relies on the traditional trial-and-error methods of pharmaceutical scientists. This approach is laborious, time-consuming and costly. Recently, deep learning has been widely applied in many challenging domains because of its important capability of automatic feature extraction. The aim of the present research is to apply deep learning methods to predict pharmaceutical formulations. In this paper, two types of dosage forms were chosen as model systems. Evaluation criteria suitable for pharmaceutics were applied to assess the performance of the models. Moreover, an automatic dataset selection algorithm was developed for selecting the representative data as validation and test datasets. Six machine learning methods were compared with deep learning. Results showed that the accuracies of both two deep neural networks were above 80% and higher than other machine learning models; the latter showed good prediction of pharmaceutical formulations. In summary, deep learning employing an automatic data splitting algorithm and the evaluation criteria suitable for pharmaceutical formulation data was developed for the prediction of pharmaceutical formulations for the first time. The cross-disciplinary integration of pharmaceutics and artificial intelligence may shift the paradigm of pharmaceutical research from experience-dependent studies to data-driven methodologies.
format Online
Article
Text
id pubmed-6362259
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-63622592019-02-14 Deep learning for in vitro prediction of pharmaceutical formulations Yang, Yilong Ye, Zhuyifan Su, Yan Zhao, Qianqian Li, Xiaoshan Ouyang, Defang Acta Pharm Sin B Original article Current pharmaceutical formulation development still strongly relies on the traditional trial-and-error methods of pharmaceutical scientists. This approach is laborious, time-consuming and costly. Recently, deep learning has been widely applied in many challenging domains because of its important capability of automatic feature extraction. The aim of the present research is to apply deep learning methods to predict pharmaceutical formulations. In this paper, two types of dosage forms were chosen as model systems. Evaluation criteria suitable for pharmaceutics were applied to assess the performance of the models. Moreover, an automatic dataset selection algorithm was developed for selecting the representative data as validation and test datasets. Six machine learning methods were compared with deep learning. Results showed that the accuracies of both two deep neural networks were above 80% and higher than other machine learning models; the latter showed good prediction of pharmaceutical formulations. In summary, deep learning employing an automatic data splitting algorithm and the evaluation criteria suitable for pharmaceutical formulation data was developed for the prediction of pharmaceutical formulations for the first time. The cross-disciplinary integration of pharmaceutics and artificial intelligence may shift the paradigm of pharmaceutical research from experience-dependent studies to data-driven methodologies. Elsevier 2019-01 2018-09-28 /pmc/articles/PMC6362259/ /pubmed/30766789 http://dx.doi.org/10.1016/j.apsb.2018.09.010 Text en © 2018 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original article
Yang, Yilong
Ye, Zhuyifan
Su, Yan
Zhao, Qianqian
Li, Xiaoshan
Ouyang, Defang
Deep learning for in vitro prediction of pharmaceutical formulations
title Deep learning for in vitro prediction of pharmaceutical formulations
title_full Deep learning for in vitro prediction of pharmaceutical formulations
title_fullStr Deep learning for in vitro prediction of pharmaceutical formulations
title_full_unstemmed Deep learning for in vitro prediction of pharmaceutical formulations
title_short Deep learning for in vitro prediction of pharmaceutical formulations
title_sort deep learning for in vitro prediction of pharmaceutical formulations
topic Original article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362259/
https://www.ncbi.nlm.nih.gov/pubmed/30766789
http://dx.doi.org/10.1016/j.apsb.2018.09.010
work_keys_str_mv AT yangyilong deeplearningforinvitropredictionofpharmaceuticalformulations
AT yezhuyifan deeplearningforinvitropredictionofpharmaceuticalformulations
AT suyan deeplearningforinvitropredictionofpharmaceuticalformulations
AT zhaoqianqian deeplearningforinvitropredictionofpharmaceuticalformulations
AT lixiaoshan deeplearningforinvitropredictionofpharmaceuticalformulations
AT ouyangdefang deeplearningforinvitropredictionofpharmaceuticalformulations